Test & measurement


T 24


he construction of a new building prompted one of Denmark’s largest pharmacy businesses to invest in Vaisala’s viewLinc Continuous Monitoring System (CMS) to protect the production, handling and


storage of medicines. Regionsapoteket Midtjylland produces and distributes pharmaceutical products, serving customers throughout the central Jutland region of Denmark, and the new monitoring system was installed at the new facility in Aarhus as well as the company’s site in Gødstrup near Herning. With GxP regulatory compliance as a key objective, the CMS was supplied, installed and commissioned by Insatech, Vaisala’s local distributor, and partner for Regionsapoteket Midtjylland.


DATA RELIABILITY IN GXP ENVIRONMENTS To meet the GxP regulatory requirements, the Vaisala viewLinc CMS was configured to monitor temperature, particles, humidity, and pressure, as well as alarms from water treatment systems, isolators, and safety cabinets in Regionsapoteket Midtjylland's medicine production, handling, and storage facilities. The system logs measurement data from the respective measurement points as well as the use of the monitoring system (including entry log, alarm handling, communication errors, instrumentation errors, etc.), ensuring an accurate representation of the production environment at any given time. With viewLinc, Regionsapoteket can verify and prove to auditors that medications are produced, stored, and handled under the correct environmental conditions. Data


May 2024 Instrumentation Monthly


DANISH PHARMACIES INVEST IN HI-TECH ENVIRONMENTAL MONITORING SYSTEM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84